APC Anti-Human IgD Antibody [IA6-2] (AGEL1852)

APC Anti-Human IgD Antibody [IA6-2]

The Human IGD Monoclonal Antibody (APC Conjugated, IA6-2) is a cutting-edge tool for researchers exploring the immune system and its responses. This monoclonal antibody is specifically designed to target IGD, a crucial component involved in immune modulation and response pathways. With its high sensitivity and specificity for human samples, this antibody is well-suited for a variety of applications, including flow cytometry and immunofluorescence studies.IGD, also known as Immunoglobulin D, is a key player in the adaptive immune system, contributing to antibody production and immune signaling.

By targeting IGD with this monoclonal antibody, researchers can gain valuable insights into its role in immune function and potential implications in diseases such as autoimmune disorders and infectious diseases.By using the Human IGD Monoclonal Antibody (APC Conjugated, IA6-2), researchers can unlock new avenues of investigation in immunology and disease research. This antibody opens up possibilities for studying the dynamics of the immune system and how IGD influences immune responses, paving the way for innovative therapeutic strategies and interventions.

Isotype:	Mouse IgG2a, κ
Isotype Control:	APC Mouse IgG2a, κ Isotype Control[C1.18.4]
Form:	Liquid
Conjugation:	APC
Recommended Use:	Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use.
Spectrum: